Efficacy and safety of roxadustat for the treatment of renal anemia in patients undergoing peritoneal dialysis: a systematic review and meta-analysis.
Evidence concerning hemoglobin target attainment, high-density lipoprotein cholesterol, and long-term safety remains insufficient, and comparative clinical superiority of roxadustat-based over ESA-based strategies in PD is insufficient.
Yuan-Yuan Zhou, Jian-Shan Liao, Wen-Rui Huang et al.
· Renal Failure · 0 citations